{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:41:34Z","timestamp":1794220894790,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404140"],"award-info":[{"award-number":["82404140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the innovation of science and technology of Fujian Province","award":["2020Y9022"],"award-info":[{"award-number":["2020Y9022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16198-9","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T14:01:42Z","timestamp":1755439302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like dermatitis by modulating ERK and NF-\u03baB signaling pathways in mice"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9920-5599","authenticated-orcid":false,"given":"Meng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3397-0907","authenticated-orcid":false,"given":"Ruihan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-3651","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5249-4598","authenticated-orcid":false,"given":"Danqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-0322","authenticated-orcid":false,"given":"Caifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"16198_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. Lancet 397, 1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6 (2021).","journal-title":"Lancet"},{"key":"16198_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W., Read, C. & Pathophysiology Clinical presentation, and treatment of psoriasis: A review. JAMA 323, 1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006 (2020).","journal-title":"JAMA"},{"key":"16198_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.15840","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki, F. & Psoriasis Comorbidities. J. Dermatol. 48, 732\u2013740. https:\/\/doi.org\/10.1111\/1346-8138.15840 (2021).","journal-title":"J. Dermatol."},{"key":"16198_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman, N. J. Management of psoriasis as a systemic disease: what is the evidence? Br. J. Dermatol. 182, 840\u2013848. https:\/\/doi.org\/10.1111\/bjd.18245 (2020).","journal-title":"Br. J. Dermatol."},{"key":"16198_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1159\/000528945","volume":"239","author":"AW Armstrong","year":"2023","unstructured":"Armstrong, A. W. et al. Patient perspectives on psoriatic disease burden: results from the global psoriasis and beyond survey. Dermatology 239, 621\u2013634. https:\/\/doi.org\/10.1159\/000528945 (2023).","journal-title":"Dermatology"},{"key":"16198_CR6","doi-asserted-by":"publisher","first-page":"2247106","DOI":"10.1080\/09546634.2023.2247106","volume":"34","author":"S Min","year":"2023","unstructured":"Min, S., Wang, D., Xia, J., Lin, X. & Jiang, G. The economic burden and quality of life of patients with psoriasis treated with biologics in China. J. Dermatolog Treat. 34, 2247106. https:\/\/doi.org\/10.1080\/09546634.2023.2247106 (2023).","journal-title":"J. Dermatolog Treat."},{"key":"16198_CR7","doi-asserted-by":"publisher","unstructured":"Bakshi, H., Nagpal, M., Singh, M., Dhingra, G. A. & Aggarwal, G. Treatment of psoriasis: A comprehensive review of entire therapies. Curr. Drug Saf. 15 https:\/\/doi.org\/10.2174\/1574886315666200128095958 (2020).","DOI":"10.2174\/1574886315666200128095958"},{"key":"16198_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbiotec.2019.12.016","volume":"309","author":"M Bertelli","year":"2020","unstructured":"Bertelli, M. et al. A natural compound with promising Pharmacological activities. J. Biotechnol. 309, 29\u201333. https:\/\/doi.org\/10.1016\/j.jbiotec.2019.12.016 (2020). Hydroxytyrosol.","journal-title":"J. Biotechnol."},{"key":"16198_CR9","doi-asserted-by":"publisher","unstructured":"Velotti, F. & Bernini, R. Hydroxytyrosol interference with inflammaging via modulation of inflammation and autophagy. Nutrients 15 https:\/\/doi.org\/10.3390\/nu15071774 (2023).","DOI":"10.3390\/nu15071774"},{"key":"16198_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.fct.2013.01.030","volume":"55","author":"D Au\u00f1on-Calles","year":"2013","unstructured":"Au\u00f1on-Calles, D., Canut, L. & Visioli, F. Toxicological evaluation of pure Hydroxytyrosol. Food Chem. Toxicol. 55, 498\u2013504. https:\/\/doi.org\/10.1016\/j.fct.2013.01.030 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"16198_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phrs.2013.06.002","volume":"74","author":"D Au\u00f1on-Calles","year":"2013","unstructured":"Au\u00f1on-Calles, D., Giordano, E., Bohnenberger, S. & Visioli, F. Hydroxytyrosol is not genotoxic in vitro. Pharmacol. Res. 74, 87\u201393. https:\/\/doi.org\/10.1016\/j.phrs.2013.06.002 (2013).","journal-title":"Pharmacol. Res."},{"key":"16198_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.foodres.2017.11.053","volume":"105","author":"M Robles-Almazan","year":"2018","unstructured":"Robles-Almazan, M. et al. Hydroxytyrosol: bioavailability, toxicity, and clinical applications. Food Res. Int. 105, 654\u2013667. https:\/\/doi.org\/10.1016\/j.foodres.2017.11.053 (2018).","journal-title":"Food Res. Int."},{"key":"16198_CR13","doi-asserted-by":"publisher","unstructured":"D\u2019Angelo, C., Franceschelli, S., Quiles, J. L. & Speranza, L. Wide biological role of hydroxytyrosol: possible therapeutic and preventive properties in cardiovascular diseases. Cells 9 https:\/\/doi.org\/10.3390\/cells9091932 (2020).","DOI":"10.3390\/cells9091932"},{"key":"16198_CR14","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.2174\/1381612824666180522110314","volume":"24","author":"MCL de Las Hazas","year":"2018","unstructured":"de Las Hazas, M. C. L., Rubio, L., Macia, A. & Motilva, M. J. Hydroxytyrosol: emerging trends in potential therapeutic applications. Curr. Pharm. Des. 24, 2157\u20132179. https:\/\/doi.org\/10.2174\/1381612824666180522110314 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"16198_CR15","doi-asserted-by":"publisher","unstructured":"Micheli, L. et al. Role of Hydroxytyrosol and Oleuropein in the prevention of aging and related disorders: focus on neurodegeneration, skeletal muscle dysfunction and gut microbiota. Nutrients 15 https:\/\/doi.org\/10.3390\/nu15071767 (2023).","DOI":"10.3390\/nu15071767"},{"key":"16198_CR16","doi-asserted-by":"publisher","unstructured":"Peyrol, J., Riva, C. & Amiot, M. J. Hydroxytyrosol in the prevention of the metabolic syndrome and related disorders. Nutrients 9 https:\/\/doi.org\/10.3390\/nu9030306 (2017).","DOI":"10.3390\/nu9030306"},{"key":"16198_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/08923973.2022.2143373","volume":"45","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Anti-psoriasis activities of Hydroxytyrosol on HaCaT cells under psoriatic inflammation in vitro. Immunopharmacol. Immunotoxicol. 45, 328\u2013333. https:\/\/doi.org\/10.1080\/08923973.2022.2143373 (2023).","journal-title":"Immunopharmacol. Immunotoxicol"},{"key":"16198_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1871530317666171114114321","volume":"18","author":"C Santangelo","year":"2018","unstructured":"Santangelo, C. et al. Anti-inflammatory activity of extra Virgin Olive oil polyphenols: which role in the prevention and treatment of Immune-Mediated inflammatory diseases?? Endocr. Metab. Immune Disord Drug Targets. 18, 36\u201350. https:\/\/doi.org\/10.2174\/1871530317666171114114321 (2018).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"key":"16198_CR19","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1002\/cpim.71","volume":"125","author":"TP Singh","year":"2019","unstructured":"Singh, T. P., Zhang, H. H., Hwang, S. T. & Farber, J. M. IL-23- and Imiquimod-Induced models of experimental psoriasis in mice. Curr. Protoc. Immunol. 125, e71. https:\/\/doi.org\/10.1002\/cpim.71 (2019).","journal-title":"Curr. Protoc. Immunol."},{"key":"16198_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar, R. S., Gudjonsson, J. E. & Ward, N. L. Mouse models of psoriasis: A comprehensive review. J. Invest. Dermatol. 142, 884\u2013897. https:\/\/doi.org\/10.1016\/j.jid.2021.06.019 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"16198_CR21","unstructured":"Gr\u00e4n, F., Kerstan, A., Serfling, E., Goebeler, M. & Muhammad, K. Current developments in the immunology of psoriasis. Yale J. Biol. Med. 93, 97\u2013110(2020)."},{"key":"16198_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos, S., Mohebiany, A. N., Waisman, A. & Kurschus, F. C. Imiquimod-Induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J. Invest. Dermatol. 139, 1110\u20131117. https:\/\/doi.org\/10.1016\/j.jid.2019.01.006 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"16198_CR23","doi-asserted-by":"publisher","unstructured":"Tokuyama, M. & Mabuchi, T. New treatment addressing the pathogenesis of psoriasis. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21207488 (2020).","DOI":"10.3390\/ijms21207488"},{"key":"16198_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y. & Guo, C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell. Death Dis. 13, 81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3 (2022).","journal-title":"Cell. Death Dis."},{"key":"16198_CR25","doi-asserted-by":"publisher","unstructured":"Yu, H. et al. Hydroxytyrosol ameliorates intervertebral disc degeneration and neuropathic pain by reducing oxidative stress and inflammation. Oxid. Med. Cell. Longev. 2022 (2240894). https:\/\/doi.org\/10.1155\/2022\/2240894 (2022).","DOI":"10.1155\/2022\/2240894"},{"key":"16198_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40199-019-00274-3","volume":"27","author":"A Smeriglio","year":"2019","unstructured":"Smeriglio, A. et al. Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model. Daru 27, 283\u2013293. https:\/\/doi.org\/10.1007\/s40199-019-00274-3 (2019).","journal-title":"Daru"},{"key":"16198_CR27","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1292\/jvms.18-0250","volume":"80","author":"Y Yonezawa","year":"2018","unstructured":"Yonezawa, Y. et al. Anti-inflammatory effects of olive-derived Hydroxytyrosol on lipopolysaccharide-induced inflammation in RAW264.7 cells. J. Vet. Med. Sci. 80, 1801\u20131807. https:\/\/doi.org\/10.1292\/jvms.18-0250 (2018).","journal-title":"J. Vet. Med. Sci."},{"key":"16198_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B. & Lizzul, P. F. NF-\u03baB: an essential transcription factor in psoriasis. J. Dermatol. Sci. 69, 89\u201394. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.11.002 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"16198_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2018.11.031","volume":"66","author":"X Huang","year":"2019","unstructured":"Huang, X. et al. ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK\/IL-17 signaling pathway. Int. Immunopharmacol. 66, 236\u2013241. https:\/\/doi.org\/10.1016\/j.intimp.2018.11.031 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"16198_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Signaling pathways and targeted therapies for psoriasis. Signal. Transduct. Target. Ther. 8, 437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"16198_CR31","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.26355\/eurrev_202006_21544","volume":"24","author":"YB Yu","year":"2020","unstructured":"Yu, Y. B., Zhuang, H. Z., Ji, X. J., Dong, L. & Duan, M. L. Hydroxytyrosol suppresses LPS-induced intrahepatic inflammatory responses via Inhibition of ERK signaling pathway activation in acute liver injury. Eur. Rev. Med. Pharmacol. Sci. 24, 6455\u20136462. https:\/\/doi.org\/10.26355\/eurrev_202006_21544 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"16198_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuroscience.2019.12.005","volume":"426","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Hydroxytyrosol inhibits LPS-Induced neuroinflammatory responses via suppression of TLR-4-Mediated NF-\u03baB P65 activation and ERK signaling pathway. Neuroscience 426, 189\u2013200. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.12.005 (2020).","journal-title":"Neuroscience"},{"key":"16198_CR33","doi-asserted-by":"publisher","first-page":"e1900019","DOI":"10.1002\/mnfr.201900019","volume":"63","author":"M Aparicio-Soto","year":"2019","unstructured":"Aparicio-Soto, M. et al. Olive-Oil-Derived polyphenols effectively attenuate inflammatory responses of human keratinocytes by interfering with the NF-\u03baB pathway. Mol. Nutr. Food Res. 63, e1900019. https:\/\/doi.org\/10.1002\/mnfr.201900019 (2019).","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16198-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T14:01:44Z","timestamp":1755439304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16198-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16198"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16198-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Fujian Provincial Hospital and all experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Specifically, animal experiments were performed in compliance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval for animal experiments"}}],"article-number":"30125"}}